| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Captafol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00940
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Fungicide |
| DME Modulation |
Captafol inhibits the drug-metabolizing activity of DME GSTP1 |
[1] |
| Captan |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00941
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Fungicide |
| DME Modulation |
Captan inhibits the drug-metabolizing activity of DME GSTP1 |
[1] |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| 2-dichlorobenzene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00886
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
2-dichlorobenzene inhibits the drug-metabolizing activity of DME GSTP1 |
[2] |
| Monocrotophos |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01062
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Monocrotophos up-regulates the expression of DME GSTP1 |
[3] |
| Parathion |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01064
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Parathion induces the drug-metabolizing activity of DME GSTP1 |
[4] |
| Sulfotepp |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01608
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Sulfotepp inhibits the expression of DME GSTP1 |
[5] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| 2-butenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01122
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-butenal inhibits the drug-metabolizing activity of DME GSTP1 |
[6] |
| Acrolein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01186
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrolein inhibits the drug-metabolizing activity of DME GSTP1 |
[6] |
| Cadmium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium up-regulates the expression of DME GSTP1 |
[7] |
| Chloropicrin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Chloropicrin inhibits the expression of DME GSTP1 |
[8] |
| Formaldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde induces the drug-metabolizing activity of DME GSTP1 |
[9] |
| Kaempferol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01353
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Kaempferol inhibits the drug-metabolizing activity of DME GSTP1 |
[10] |
| Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dinophysistoxin 1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00813
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Biotoxin |
| DME Modulation |
Dinophysistoxin 1 up-regulates the expression of DME GSTP1 |
[11] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene induces the drug-metabolizing activity of DME GSTP1 |
[12] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 2-tert-butylhydroquinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01129
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
2-tert-butylhydroquinone up-regulates the expression of DME GSTP1 |
[13] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| 3-morpholinopropyl isothiocyanate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01142
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
3-morpholinopropyl isothiocyanate induces the drug-metabolizing activity of DME GSTP1 |
[12] |
| Cumene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01003
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
Cumene inhibits the drug-metabolizing activity of DME GSTP1 |
[2] |
| Ethyl benzene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01007
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
Ethyl benzene inhibits the drug-metabolizing activity of DME GSTP1 |
[2] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| Coal tar |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00755
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Coal tar up-regulates the expression of DME GSTP1 |
[14] |
| Flavonoids |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00858
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Flavonoids inhibits the expression of DME GSTP1 |
[15] |
| Polyphenols |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01578
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Polyphenols inhibits the expression of DME GSTP1 |
[16] |
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution inhibits the expression of DME GSTP1 |
[17] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| Alpha-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01192
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Alpha-naphthoflavone inhibits the expression of DME GSTP1 |
[18] |
| Benzyl isothiocyanate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01217
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Benzyl isothiocyanate inhibits the drug-metabolizing activity of DME GSTP1 |
[19] |
| Bilirubin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00877
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Bilirubin inhibits the expression of DME GSTP1 |
[20] |
| Cinnamic aldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01253
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Cinnamic aldehyde inhibits the drug-metabolizing activity of DME GSTP1 |
[6] |
| Galangin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01308
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Galangin inhibits the drug-metabolizing activity of DME GSTP1 |
[10] |
| Indioside D |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01552
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Indioside D induces the drug-metabolizing activity of DME GSTP1 |
[21] |
| Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Apple polyphenol extract |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00757
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Plant Extract |
| DME Modulation |
Apple polyphenol extract up-regulates the expression of DME GSTP1 |
[22] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 28 Xenobiotics
|
| Amitriptyline |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00337
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Amitriptyline inhibits the drug-metabolizing activity of DME GSTP1 |
[23] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide up-regulates the expression of DME GSTP1 |
[24] |
| Celecoxib |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00013
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Celecoxib up-regulates the expression of DME GSTP1 |
[25] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME GSTP1 |
[26] |
| Clomipramine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00285
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Clomipramine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 |
[23] |
| Clozapine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00209
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Clozapine inhibits the drug-metabolizing activity of DME GSTP1 |
[27] |
| Decitabine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Decitabine induces the drug-metabolizing activity of DME GSTP1 |
[28] |
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00290
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dopamine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 |
[29] |
| Doxepin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00354
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxepin inhibits the drug-metabolizing activity of DME GSTP1 |
[23] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride induces the drug-metabolizing activity of DME GSTP1 |
[30] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the expression of DME GSTP1 |
[31] |
| Ethacrynic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00032
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ethacrynic acid inhibits the drug-metabolizing activity of DME GSTP1 in Human leukemia cell line (HL-60) (IC50 = 3.4 microM) |
[32] |
| Fluorouracil |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00037
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fluorouracil up-regulates the expression of DME GSTP1 |
[33] |
| Haloperidol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00045
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Haloperidol inhibits the expression of DME GSTP1 |
[34] |
| Hydralazine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00362
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydralazine up-regulates the expression of DME GSTP1 |
[35] |
| Hydrogen peroxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrogen peroxide inhibits the drug-metabolizing activity of DME GSTP1 |
[36] |
| Imipramine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00300
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Imipramine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 |
[23] |
| Leflunomide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Leflunomide up-regulates the expression of DME GSTP1 |
[37] |
| Obeticholic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00165
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Obeticholic acid inhibits the drug-metabolizing activity of DME GSTP1 |
[38] |
| Oxaliplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00207
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Oxaliplatin up-regulates the expression of DME GSTP1 |
[39] |
| Phenobarbital |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00410
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Phenobarbital inhibits the drug-metabolizing activity of DME GSTP1 |
[40] |
| Rifampin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00223
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rifampin induces the drug-metabolizing activity of DME GSTP1 |
[41] |
| Selenomethionine Se-75 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00324
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Selenomethionine Se-75 induces the drug-metabolizing activity of DME GSTP1 |
[42] |
| Tetracycline |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00200
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tetracycline inhibits the expression of DME GSTP1 |
[43] |
| Aclarubicin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00450
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Aclarubicin induces the drug-metabolizing activity of DME GSTP1 |
[30] |
| Artemisinine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00449
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Artemisinine inhibits the drug-metabolizing activity of DME GSTP1 |
[44] |
| Chlorobenzene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00442
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Chlorobenzene induces the drug-metabolizing activity of DME GSTP1 |
[45] |
| Hemin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01328
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Hemin up-regulates the expression of DME GSTP1 |
[46] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Curcumin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00683
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Curcumin inhibits the drug-metabolizing activity of DME GSTP1 |
[6] |
| Epigallocatechin gallate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Epigallocatechin gallate inhibits the expression of DME GSTP1 |
[47] |
| Oltipraz |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00605
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Oltipraz up-regulates the expression of DME GSTP1 |
[48], [49] |
| SGX301 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00579
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
SGX301 inhibits the drug-metabolizing activity of DME GSTP1 |
[50] |
| Vitamin E |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Vitamin E up-regulates the expression of DME GSTP1 |
[51] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
| Butyric acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01230
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
Butyric acid inhibits the expression of DME GSTP1 |
[52] |
| Artesunate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00540
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Artesunate inhibits the drug-metabolizing activity of DME GSTP1 |
[53] |
| Bufalin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00665
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bufalin inhibits the drug-metabolizing activity of DME GSTP1 |
[54] |
| Camptothecin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00597
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Camptothecin induces the drug-metabolizing activity of DME GSTP1 |
[55] |
| Glutathione |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00542
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Glutathione inhibits the drug-metabolizing activity of DME GSTP1 |
[56] |
| Procysteine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00615
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Procysteine up-regulates the expression of DME GSTP1 and leads to increasing the drug-metabolizing activity of this enzyme |
[57] |
| Salvin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00614
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Salvin up-regulates the expression of DME GSTP1 |
[58], [59] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Eriodictyol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01290
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Eriodictyol inhibits the drug-metabolizing activity of DME GSTP1 |
[10] |
| Quercetin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin inhibits the expression of DME GSTP1 |
[60] |
| Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Sodium arsenite induces the drug-metabolizing activity of DME GSTP1 |
[61] |
| Tetradecanoylphorbol acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00599
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Tetradecanoylphorbol acetate up-regulates the expression of DME GSTP1 and leads to increasing the drug-metabolizing activity of this enzyme |
[62] |
| Xanthohumol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00636
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Xanthohumol up-regulates the expression of DME GSTP1 |
[63] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Eugenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00885
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
Eugenol inhibits the drug-metabolizing activity of DME GSTP1 |
[64] |
| ICG-001 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 up-regulates the expression of DME GSTP1 |
[65] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| 4-hydroxy-2-nonenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00869
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME GSTP1 |
[6] |
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone induces the drug-metabolizing activity of DME GSTP1 |
[66] |
| MG-132 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01219
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
MG-132 induces the drug-metabolizing activity of DME GSTP1 |
[67] |
| Oxidopamine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01418
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Oxidopamine inhibits the drug-metabolizing activity of DME GSTP1 |
[68] |
| Phenylmercuric acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Phenylmercuric acetate induces the drug-metabolizing activity of DME GSTP1 |
[69] |
| WR-1065 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00801
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
WR-1065 inhibits the expression of DME GSTP1 |
[70] |
| Other Chemical Compound(s) or Element(s) |
| Food Additive |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| 2-heptanone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00928
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Food Additive |
| DME Modulation |
2-heptanone inhibits the drug-metabolizing activity of DME GSTP1 |
[2] |
| 4-propylphenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00929
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Food Additive |
| DME Modulation |
4-propylphenol inhibits the drug-metabolizing activity of DME GSTP1 |
[64] |
|
|
|
|
|
|